Common Contracts
3 similar Subscription Agreement contracts by AC Immune SA
EX-10.9 16 d16439dex109.htm EX-10.9 Execution Copy SUBSCRIPTION AGREEMENT made as of 16 October 2015 by and among c/o Temasek Holdings (Private) Limited 60B Orchard Road #06-18 Tower 2 The Atrium@Orchard Singapore 238891 (hereinafter “V-Sciences”)...Subscription Agreement • May 5th, 2020
The Company intends to increase its share capital in a fifth round of financing (the “Series E Financing Round”) by way of issuance of up to 20’536 Series E Preferred Shares in the Company with a nominal value of CHF 5.00 per Series E Preferred Share, each to be fully paid-in in cash, thereby increasing the issued share capital of the Company by a nominal amount of up to CHF 102’680.
SUBSCRIPTION AGREEMENT made as of 16 October 2015 by and amongSubscription Agreement • May 31st, 2016 • AC Immune SA • Pharmaceutical preparations
The Company intends to increase its share capital in a fifth round of financing (the “Series E Financing Round”) by way of issuance of up to 20’536 Series E Preferred Shares in the Company with a nominal value of CHF 5.00 per Series E Preferred Share, each to be fully paid-in in cash, thereby increasing the issued share capital of the Company by a nominal amount of up to CHF 102’680.
SUBSCRIPTION AGREEMENT made as of 16 October 2015 by and amongSubscription Agreement • November 24th, 2015 • AC Immune SA • Pharmaceutical preparations
The Company intends to increase its share capital in a fifth round of financing (the “Series E Financing Round”) by way of issuance of up to 20’536 Series E Preferred Shares in the Company with a nominal value of CHF 5.00 per Series E Preferred Share, each to be fully paid-in in cash, thereby increasing the issued share capital of the Company by a nominal amount of up to CHF 102’680.
